DistantNews
Support us
🇹🇼 Taiwan /Health & Science

Cancer cells' 'invisibility cloak' fails, exposing new weakness to immune system, study finds

From Liberty Times · () Chinese

Translated from Chinese, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • Researchers discovered that cancer cells' method of shutting down identification signals to evade immune attacks may expose new weaknesses.
  • A study led by Baylor College of Medicine found that when cancer cells lose the MHC-I molecule, they can be targeted by a different immune mechanism.
  • This discovery suggests the human immune system is more adaptable than previously thought, potentially offering new avenues for cancer therapy development.

Cancer cells often deactivate surface identification signals to hide from the immune system. However, new research from Baylor College of Medicine reveals this "invisibility cloak" might create new vulnerabilities.

When cancer cells lose a crucial molecule called MHC-I, they can evade certain immune cells but become targets for other immune mechanisms.

— ResearchersExplaining the core finding of the study.

The study, published in Nature Immunology, found that when cancer cells lose a crucial molecule called MHC-I, they can evade certain immune cells but become targets for other immune mechanisms. Scientists previously believed that losing MHC-I allowed cancer cells to escape detection by CD8 T cells, posing a significant hurdle for immunotherapy.

Researchers discovered that even without MHC-I, CD4 T cells can still recognize cancer cells through other signals and trigger an immune response. This indicates that cancer cells, despite disabling their "ID," may not completely disappear from the immune system's view. The findings suggest the human immune system possesses greater flexibility than previously understood, retaining alternative detection and counterattack channels even when cancer cells alter their characteristics.

This indicates that cancer cells, despite disabling their "ID," may not completely disappear from the immune system's view.

— ResearchersDescribing the implications of the immune system's adaptability.

While this research is foundational and focuses on understanding immune recognition of cancer cells, it does not yet represent a new cancer therapy. However, further clarification of this recognition mechanism could aid in developing novel immunotherapies, particularly for tumors that have lost MHC-I. Many cancers utilize the shutdown of MHC-I to evade immune assault, and this study highlights that this common escape tactic may come at a cost, potentially opening new directions for cancer research.

Many cancers utilize the shutdown of MHC-I to evade immune assault, and this study highlights that this common escape tactic may come at a cost, potentially opening new directions for cancer research.

— ResearchersHighlighting the significance of the discovery for future cancer research.
DistantNews Editorial

Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog